NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • NIHR Imperial BRC Primary Care Research Unit (PCRU)
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Stories by Paul Craven

Therapeutic Defining the optimal therapy for primary HIV infection

Therapeutic Defining the optimal therapy for primary HIV infection

Published on 27th June 2016
Diagnostic A new diagnostic for detection of latent tuberculosis

Diagnostic A new diagnostic for detection of latent tuberculosis

Published on 27th June 2016
Diagnostic Using Next-Generation Sequencing to inform and control an outbreak

Diagnostic Using Next-Generation Sequencing to inform and control an outbreak

Published on 27th June 2016
First in HumanTherapeutic Using the novel hormone kisspeptin to improve IVF treatment

First in HumanTherapeutic Using the novel hormone kisspeptin to improve IVF treatment

Published on 26th June 2016
DeviceTherapeutic Diabetes technology research

DeviceTherapeutic Diabetes technology research

Published on 26th June 2016
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Prevention Detection of Asymptomatic Malaria Cases Using Rapid Diagnostic Tools
  • DiagnosticPrevention St Mary’s Pilots Rapid Blood Test to Detect Life-Threatening Conditions in Children
  • Prevention Imperial Recognised as a Centre of Excellence in Focused Ultrasound
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre